KNCV Publications

Overview of recent KNCV Publications

Sara Suliman, Puck T. Pelzer, Moagi Shakua, Virginie Rozot, Simon C. Mendelsohn; Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2020. ScienceDirect. 2021, September 15; S0264-410X(21)01154-3. Full article/abstract.

Tesema E, Wares F, Bedru A, Negeri C, Molla Y, Gemechu D, Kassa A, Tsegaye F, Taye L.; Experiences of introducing new drugs for drug-resistant TB at the ALERT Hospital, Addis Ababa, Ethiopia. 2017-2019; Public Health Action. 2021 Jun 21;11(2):50-52. Abstract.

Shiferaw MB, Sinishaw MA, Amare D, Alem G, Asefa D, Klinkenberg E.; Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia; PLoS One. 2021 Jun 11;16(6):e0253177. Abstract/full article.

Gurung SC, Dixit K, Rai B, Dhital R, Paudel PR, Acharya S, Budhathoki G, Malla D, Levy JW, et al.’ Comparative Yield of Tuberculosis during Active Case Finding Using GeneXpert or Smear Microscopy for Diagnostic Testing in Nepal: A Cross-Sectional Study; Trop Med Infect Dis. 2021 Apr 14;6(2):50. Abstract.

Lyakurwa D, Lyimo J, Mulder C, Pelzer PT, Koppelaar I, Heus M.; Assessment of training and mentoring for DR-TB care decentralization in Tanzania; Hum Resour Health. 2021 Apr 26;19(1):56. Abstract/full article.

Gurung SC, Rai B, Dixit K, Worrall E, Paudel PR, Dhital R, Sah MK, Pandit RN, at al. How to reduce household costs for people with tuberculosis: a longitudinal costing survey in Nepal; Health Policy Plan. 2021 Jun 3;36(5):594-605. Abstract/full article.

Petra de Haas, Bazezew Yenewb, Endale Mengeshac, Andrii Slyzkyia, Zewdu Gash, et al. The Simple One-Step (SOS) Stool Processing Method for Use with the Xpert MTB/RIF Assay for a Child-Friendly Diagnosis of Tuberculosis Closer to the Point of Care. Journal of Clinical Microbiology, 2021, JCM. 00406-21. Abstract.

Van de Berg S.E.J., Pelzer P.T., van der Land A.J., Abdrakhmanova E. et al. Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients. BMC Public Health. 2021 July 16;21:1404. Full article.

Abidi S, Achar J, Assao Neino MM, Dravniece G, Makhmudova M, Myrzaliev B et al. Standardised shorter regimens versus individualised longer regimens for rifampin – or multidrug-resistant tuberculosis. Eur Respir J 2020;55(3). Abstract

Linh NN, Wares F, Cocozza AM, Uplekar M, Raviglione M. No universal access to drug-resistant tuberculosis care without engaging all health care providers. Int J Tuberc Lung Dis 2020 1;24(1):118-23. Abstract

Nguyen HV, Tiemersma EW, Nguyen HB, Cobelens FGJ, Mirtskhulava V, de Haas P et al. The second national tuberculosis prevalence survey in Vietnam. PLoS One. 2020 23;15(4) Abstract

Onazi O, Adejumo AO, Redwood L, Gidado M, Daniel OJ, Mitchell EMH. et al. Community health care workers in pursuit of TB: Discourses and dilemmas. Soc Sci Med. 2020;246:112756. Abstract

Rai B, Dixit K, Aryal TP, Mishra G, Siqueira-Filha NT, Levy JW, Rest JV et al. Developing Feasible, Locally Appropriate Socioeconomic Support for TB-Affected Households in Nepal. Trop Med Infect Dis. 2020;5(2):98. Abstract

Adejumo OA, Olusola-Faleye B, Adepoju VA, Gidado M, Onoh MO, Adegboye O, et al. The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria. Trans R Soc Trop Med Hyg. 2020;114(6):415-423. Abstract

Parwati CG, Farid MN, Nasution HS, Basri C, Gebhard A, Tiemersma EW et al. Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia. Int J Tuberc Lung Dis. 2020;24(2):250-257. Abstract

Gafar F, Ochi T, Van’t Boveneind-Vrubleuskaya N, Erkens C, van den Hof S, van der Werf TS, et al. Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data. Eur Respir J. 2020. Abstract

Anh LTN, M V Kumar A, Ramaswamy G, Htun T, Quelapio M, Gebhard A, et al. High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam. Trop Med Infect Dis. 2020;5(1):43. Abstract

Migambi P, Gasana M, Uwizeye CB, Kamanzi E, Kalisvaart N, Klinkenberg E et al. Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control. PLoS One. 2020 3;15(4). Abstract

Mekonnen A, Collins JM, Klinkenberg E, Assefa D, Aseffa A, Ameni G, et al. Tuberculosis knowledge and attitude among non-health science university students needs attention: a cross-sectional study in three Ethiopian universities. BMC Public Health 2020;20(1):631. Abstract

Spruijt I, Haile DT, Erkens C, van den Hof S, Goosen S, Ten Kate A, et al. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans. BMC Public Health 2020 12;20(1):315. Abstract

Denholm JT, Millan-Marcelo JC, Fiekert K, Denholm JT, et al. Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives. Int J Tuberc Lung Dis. 2020;24(5):21-26. Abstract

Vo LNQ, Forse RJ, Codlin AJ, Vu TN, Le GT, Levy J et al. A comparative impact evaluation of two human resource models for community-based active tuberculosis case finding in Ho Chi Minh City, Viet Nam. BMC Public Health. 2020;20(1):934. Abstract

Ineke SpruijtConnie ErkensSusan van den HofFrank Cobelens. Comment: Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study. Eur Respir J. 2020;55(4) No abstract available

Mulder C, Nkiligi E, Kondo Z, Scholten JN, What data to look for when using SUBsET for subnational tuberculosis incidence estimation, Int J Tuberc Lung Dis. 2020. No abstract available

Ruda C, Wares F, Hiruy N, et al. Streamlining TB Infection Control and Intensifying TB Screening in Ethiopian Health Facilities. J Med-Clin Res & Rev. 2020;4(3): 1-5. Full article

Erkens C, Spruijt I, van den Hof S. et al. Preventing TB among immigrants; aiming for an integrated approach to infectious diseases. Ned Tijdschr Geneeskd. 2020 Jul 16;164:D4538.Ned Tijdschr Geneeskd. 2020. PMID: 32757512 Abstract

Xia H, van den Hof S, Cobelens F, Zhou Y, Zhao B, Wang S, Zhao Y.Xia H, et al. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China. BMC Infect Dis. 2020;20(1):19. Abstract

de Vries G, Commandeur S, Erkens C, Haddad W, Jansen N, Kouw P et al. Towards selective tuberculosis screening of people in prison in a low-incidence country. Eur Respir J. 2020 9;55(4):1902209. No abstract available.

Tadesse BT, Foster BA, Latour E, Lim JY, Jerene D, Ruff A et al. Predictors of Virologic Failure Among a Cohort of HIV-infected Children in Southern Ethiopia. Pediatr Infect Dis J. 2020. Abstract

Ragonnet R, Flegg JA, Brilleman SL, Tiemersma EW, Melsew YA, McBryde ES, et al. Revisiting the Natural History of Pulmonary Tuberculosis: a Bayesian Estimation of Natural Recovery and Mortality rates. Clin Infect Dis. 2020:ciaa602. Abstract

Dixit K, Rai B, Prasad Aryal T, Mishra G, Levy JW, van Rest J et al. Research protocol for a mixed-methods study to characterise and address the socioeconomic impact of accessing TB diagnosis and care in Nepal. Wellcome Open Res.2020;5:19. Abstract

Broström S, Hallström I and Jerene D. Transitioning from child to adult-oriented HIV clinical care for adolescents living with HIV in Ethiopia: results from a retrospective cohort study. Pan Afr Med J 2020;37(13). Abstract/Full article

Datiko DG, Jerene D, Suarez P. Stigma matters in ending tuberculosis: Nationwide survey of stigma in Ethiopia. BMC Public Health. 2020;20(1):190. Abstract

Datiko D, Hadgu A, Jerene D, Suarez PG. High urban tuberculosis case notification rates can be misleading: evidence from an urban setting in Ethiopia. BMC Public Health. 2020;20(1):302. Abstract

Dememew ZG, Jerene D, Datiko DG, Hiruy N, Tadesse A, Moile T, et al. The yield of community-based tuberculosis and HIV among key populations in hotspot settings of Ethiopia: A cross-sectional implementation study. PloS One. 2020;15(5) Abstract

Sorsa A, Jerene D, Negash S, Habtamu A. Use of Xpert Contributes to Accurate Diagnosis, Timely Initiation, and Rational Use of Anti-TB Treatment Among Childhood Tuberculosis Cases in South Central Ethiopia. Pediatric Health Med Ther. 2020;11:153-60. Abstract

Datiko DG, Jerene D, Suarez P. Patient and health system delay among TB patients in Ethiopia: Nationwide mixed method cross-sectional study. BMC public health. 2020;20(1):1126. Abstract

D Habte YT, D Bekele, G Alem, D Jerene, N Hiruy, Z Gashu, et al. Factors Determining Treatment Success in Children with Drug-Sensitive Tuberculosis in Ethiopia: A Three-Year Retrospective Analysis. Am J Trop Med Hyg 2020 1–5 Abstract

Gebretnsae H, Ayele BG, Hadgu T, Haregot E, Gebremedhin A, Jerene D. et al. Implementation status of household contact tuberculosis screening by health extension workers: assessment findings from programme implementation in Tigray region, northern Ethiopia. BMC health services research. 2020;20(1):72. Abstract

CG Edwards, F Wares, Dravniece, A. Gebhard, E Tiemersma, E van der Grinten et al. Introducing bedaquiline: experiences from the Challenge TB project. Int J Tuberc Lung Dis. 2020;24(10):1046-1053. Abstract/Full article

Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Erkens C et all. Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. Nat Med. 2020; Dec;26(12):1941-1949. Abstract

Adejumo OA, Daniel OJ, Adepoju AV, Femi-Adebayo T, Adebayo B et al. Challenges of Tuberculosis Control in Lagos State, Nigeria; A Qualitative Study of Health-Care Providers’ Perspectives. Niger Med J. 2020; Jan-Feb;61(1):37-41. Abstract

Jerene D. Decentralisation and task-shifting in HIV care: time to address emerging challenges.Public Health Action. 2020; Sep 21;10(3):83. No abstract available.

Adepoju AV, Ogbudebe CL, Adejumo OA, Okolie J, Inegbeboh JO et al. Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors. J Glob Infect Dis. 2020 May 22;12(2):105-111. Abstract

Spruijt I, Haile DT, van den Hof S, Fiekert K, Jansen N, Jerene D et al. Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands. BMC Public Health. 2020 Oct 23;20(1):1602. Abstract

Adejumo OA, Bowale A, Adesola S, Adepoju VA, Shogbamimu Y, Dacosta A, Seidu L, Disu OA, Omikunle TO, Abinde O, Oshindero OA.Adejumo OA, et al. Factors associated with HIV infection among clients eccessing HIV counseling and testing services in a secondary referral hospital in Lagos, Nigeria. Afr J Infect Dis. 2020 Jan 8;14(1):16-23. Abstract

Bada FO, Blok N, Okpokoro E, Dutt S, Akolo C et al. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria. PLOS ONE 2020 15(12): e0241065. Abstract

Gurung SC, Rai B, Dixit K, Worrall E, Levy JW et al. How to reduce household costs for people with tuberculosis: a longitudinal costing survey in Nepal. Health Policy Plan. 2020 Dec 20:czaa156. Abstract

Elliver M, Hallström I, Jerene D, Elliver M, et al. Pregnancy in women diagnosed with HIV on antiretroviral therapy in Ethiopia: a retrospective cohort study. Pan Afr Med J. 2020 Sep 29;37:101. Abstract

Gurung SC, Dixit K, Rai B, Levy JW, van Rest J et al. The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal. Infect Dis Poverty. 2019 Dec 3;8(1):99. Abstract

Corbett C, Kulzhabaeva A, Toichkina T, Kalmambetova G, Myrzaliev B et al. Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus. BMC Infect Dis. 2020 Oct 12;20(1):746. Abstract

Vo LNQ, Codlin AJ, Forse RJ, Nguyen NT, Levy J et al. Evaluating the yield of systematic screening for tuberculosis among three priority groups in Ho Chi Minh City, Viet Nam. Infect Dis Poverty. 2020 Dec 9;9(1):166. Abstract

Ketema L, Dememew ZG, Assefa D, Gudina T, Bedru A et al. Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study. PLoS One. 2020 Nov 19;15(11). Abstract

Zachariah R, Rust S, Thekkur P, Khogali M, Aseffa A et al. Quality, Equity and Utility of Observational Studies during 10 Years of Implementing the Structured Operational Research and Training Initiative in 72 Countries. Trop Med Infect Dis. 2020 Nov 6;5(4):167. Abstract

Boyd AT, Odume B, Sidibe K, Onotu D, Ogbanufe O et al. Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):450-453. Abstract

Gronholm PC, Nosé M, van Brakel WH, Eaton J, Fiekert K et al. Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations. Epidemiol Psychiatr Sci. 2021 Jan 28;30:e15. Abstract

Tilahun M, Shimelis E, Wogayehu T, Assefa G, Wondimagegn G, Mekonnen A, Hailu T, Bobosha K, Aseffa A.Tilahun M, et al. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia. PLoS One. 2020 Aug 4;15(8):e0236054. Abstract

Odume B, Falokun V, Chukwuogo O, Ogbudebe C, Useni S et al. Impact of COVID-19 on TB active case finding in Nigeria. Public Health Action. 2020 Dec 21;10(4):157-162. Abstract


KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.